Skip to content

Evaluation study of a cosmetic lotion containing M extract for 24 weeks

Evaluation study of a cosmetic lotion containing M extract for 24 weeks - Evaluation study of a cosmetic lotion containing M extract for 24 weeks

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000058772
Enrollment
25
Registered
2025-09-16
Start date
2025-09-17
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healty volunteers

Interventions

Use cosmetics containing M extract for 24 weeks Using a placebo cosmetic product for 24 weeks

Sponsors

Inforward, inc
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Those who meet all of the following conditions will be selected. 1)Those who have expressed their willingness to participate in the study, understood the explanation, and can provide written consent to participate in the study. 2)Healthy Japanese women aged 35 to 59 who do not meet the exclusion criteria 3)Those who are able to fill out documents such as consent forms, questionnaires, and usage diaries. 4)Those who can come to the designated facility on the measurement day 5)Those who have wrinkles at the corners of the eyes that fall mainly in the range of Grade 3.00 to 5.75 (Journal of the Japanese Society of Cosmetic Science, Vol. 30, No. 4, pp. 316-322, 2006) 6)Those who are aware of a decrease in skin firmness 7)Those who use three or fewer skincare products daily (e.g., lotion, serum, cream) *All-in-one products are excluded 8)Those who agree to their photos being used in media, etc.

Exclusion criteria

Exclusion criteria: Those who meet any of the following criteria will be excluded. 1)Those with trauma to the area to be measured 2)Those who use cosmetics, quasi-drugs, or medicines that may affect the test 3)Those who have used medicines, quasi-drugs, or cosmetics that claim to have wrinkle improvement or whitening effects on the face within 6 months prior to the start of the study 4)Those who use four or more skin care products after washing their face 5)Those who have undergone cosmetic treatments such as collagen/hyaluronic acid injections, Botox injections, chemical peeling, laser treatment, or phototherapy on the face 6)Those taking hormone medication 7)Those who are likely to be exposed to significant amounts of sunlight during the test period (such as those who play sports during the day for consecutive days) 8)Those who have previously experienced allergic reactions to cosmetics, etc. 9)Those with skin conditions such as atopic dermatitis 10)Subjects with severe hay fever (those who may be taking medication regularly during the study period) and those taking emergency medication will be excluded. 11)Those who regularly drink excessive amounts of alcohol 12)Those with a history of serious liver disease, kidney disease, heart disease, circulatory system disease, or mental illness 13)Those with severe anemia that makes it difficult for them to go out 14)Pregnant or possibly pregnant, breastfeeding, or less than six months after giving birth 15)Those who are currently participating in other clinical trials, or have participated in surveys involving the use of cosmetics, quasi-drugs, or beauty devices within the past four weeks. 16)Those taking medication due to illness 17)Anyone in your family who works for a cosmetics or pharmaceutical company 18)Persons involved in the study (working for the study sponsor or the contracted study organization) 19).Subjects who are otherwise ineligible for participation in this study by the investigater.

Design outcomes

Primary

MeasureTime frame
Visual evaluation by a physician Stratum corneum moisture content Skin viscoelasticity Replica wrinkles VISIA

Secondary

MeasureTime frame
diaryl questionnaire

Countries

Japan

Contacts

Public ContactKanako Sakurai

Inforward, inc EBISU skin research center

info@inforward.co.jp03-5793-8712

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Sep 19, 2026